BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 18646252)

  • 1. Structure-activity relationships of alphaIIb 313-320 derived peptide inhibitors of human platelet aggregation.
    Stanica RM; Benaki D; Rodis FI; Mikros E; Tsoukatos D; Tselepis A; Tsikaris V
    J Pept Sci; 2008 Nov; 14(11):1195-202. PubMed ID: 18646252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the role of adjacent amino acids to the 313-320 sequence of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3.
    Mitsios JV; Stamos G; Rodis FI; Tsironis LD; Stanica MR; Sakarellos C; Tsoukatos D; Tsikaris V; Tselepis AD
    Platelets; 2006 Aug; 17(5):277-82. PubMed ID: 16928597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of peptide inhibitors derived from the extracellular and intracellular domain of α
    Gkourogianni AV; Kiouptsi K; Koloka V; Moussis V; Tsikaris V; Bachelot-Loza C; Tsoukatos DC
    Platelets; 2018 Jan; 29(1):34-40. PubMed ID: 28351192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique interaction between alphaIIb and beta3 in the head region is essential for outside-in signaling-related functions of alphaIIbbeta3 integrin.
    Hauschner H; Landau M; Seligsohn U; Rosenberg N
    Blood; 2010 Jun; 115(22):4542-50. PubMed ID: 20308600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of synthetic peptides corresponding to residues 313-332 of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3.
    Mitsios JV; Tambaki AP; Abatzis M; Biris N; Sakarellos-Daitsiotis M; Sakarellos C; Soteriadou K; Goudevenos J; Elisaf M; Tsoukatos D; Tsikaris V; Tselepis AD
    Eur J Biochem; 2004 Feb; 271(4):855-62. PubMed ID: 14764102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a synthetic peptide corresponding to residues 313 to 320 of the alphaIIb subunit of the human platelet integrin alphaIIbbeta3 on carotid artery thrombosis in rabbits.
    Papamichael ND; Stathopoulou EM; Roussa VD; Tsironis LD; Kotsia AP; Stanica RM; Moussis V; Tsikaris V; Katsouras CS; Tselepis AD; Michalis LK
    J Pharmacol Exp Ther; 2009 May; 329(2):634-40. PubMed ID: 19244095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3.
    Afrasiabi A; Gelain F; Artoni A; Mannucci PM
    Platelets; 2008 Aug; 19(5):322-7. PubMed ID: 18791937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of residues of functional importance within the central turn motifs present in the cytoplasmic tails of integrin alphaIIb and alphaV subunits.
    Haas TA; Taherian A; Berry T; Ma X
    Thromb Res; 2008; 122(4):507-16. PubMed ID: 18328539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical residues for ligand binding in blade 2 of the propeller domain of the integrin alphaIIb subunit.
    Tamura T; Hato T; Yamanouchi J; Fujita S
    Thromb Haemost; 2004 Jan; 91(1):111-8. PubMed ID: 14691576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine-glycine-aspartic acid mimics can identify a transitional activation state of recombinant alphaIIb beta3 in human embryonic kidney 293 cells.
    Abraham DG; Nutt EM; Bednar RA; Bednar B; Gould RJ; Duong LT
    Mol Pharmacol; 1997 Aug; 52(2):227-36. PubMed ID: 9271345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calreticulin-independent regulation of the platelet integrin alphaIIbbeta3 by the KVGFFKR alphaIIb-cytoplasmic motif.
    Reilly D; Larkin D; Devocelle M; Fitzgerald DJ; Moran N
    Platelets; 2004 Feb; 15(1):43-54. PubMed ID: 14985176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmitoylated peptide, being derived from the carboxyl-terminal sequence of the integrin αIIb cytoplasmic domain, inhibits talin binding to αIIbβ₃.
    Gkourogianni A; Egot M; Koloka V; Moussis V; Tsikaris V; Panou-Pomonis E; Sakarellos-Daitsiotis M; Bachelot-Loza C; Tsoukatos DC
    Platelets; 2014; 25(8):619-27. PubMed ID: 24246298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel amino acid substitution of integrin αIIb in Glanzmann thrombasthenia confirms that the N-terminal region of the receptor plays a role in maintaining β-propeller structure.
    Pillois X; Fiore M; Heilig R; Pico M; Nurden AT
    Platelets; 2013; 24(1):77-80. PubMed ID: 22394243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disabled-2 is a novel alphaIIb-integrin-binding protein that negatively regulates platelet-fibrinogen interactions and platelet aggregation.
    Huang CL; Cheng JC; Stern A; Hsieh JT; Liao CH; Tseng CP
    J Cell Sci; 2006 Nov; 119(Pt 21):4420-30. PubMed ID: 17074833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    Nicholson NS; Panzer-Knodle SG; Salyers AK; Taite BB; King LW; Miyano M; Gorczynski RJ; Williams MH; Zupec ME; Tjoeng FS
    J Pharmacol Exp Ther; 1991 Mar; 256(3):876-82. PubMed ID: 2005585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of αIIbβ3 Ligand Binding by an αIIb Peptide that Clasps the Hybrid Domain to the βI Domain of β3.
    Lee WH; Schaffner-Reckinger E; Tsoukatos DC; Aylward K; Moussis V; Tsikaris V; Trypou P; Egot M; Baruch D; Kieffer N; Bachelot-Loza C
    PLoS One; 2015; 10(9):e0134952. PubMed ID: 26332040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel anti-platelet aggregation tripeptide from Agkistrodon acutus venom: isolation and characterization.
    Kong Y; Huo JL; Xu W; Xiong J; Li YM; Wu WT
    Toxicon; 2009 Aug; 54(2):103-9. PubMed ID: 19345702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of high-throughput screening to identify a novel alphaIIb-specific small- molecule inhibitor of alphaIIbbeta3-mediated platelet interaction with fibrinogen.
    Blue R; Murcia M; Karan C; Jirousková M; Coller BS
    Blood; 2008 Feb; 111(3):1248-56. PubMed ID: 17978171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amino acids near the RGD sequence on binding activities between αIIbβ3 integrin and fibrinogen in the presence of RGD-containing synthetic peptides from elegantin and angustatin.
    Oyama E; Takahashi H; Ishii K
    Peptides; 2017 Oct; 96():31-37. PubMed ID: 28887046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new Ser472Asn (Cab2(a+)) polymorphism localized within the αIIb "thigh" domain is involved in neonatal thrombocytopenia.
    Jallu V; Dusseaux M; Kaplan C
    Transfusion; 2011 Feb; 51(2):393-400. PubMed ID: 20723174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.